Recent trials have produced conflicting results on the benefit of epinephrine in patients with OHCA. PARAMEDIC2 was just published and is the largest randomized double-blind, placebo-controlled trial to evaluate the use of epinephrine in OHCA. Dr. Rory Spiegel joins...
Bryan Hayes is back! In this podcast, we discuss pitfalls in the use of benzodiazpines along with current evidence on adjunctive treatments including propofol,...
The World’s population is aging. By 2030, 20 percent of the US population will be over the age of 65 years. Older patients have...
Emergency medicine, critical care, and resuscitationists often use the Shock Index to identify patients with increased mortality. The Shock Index is calculated by dividing...